|
DNAJC24 expression based on
|
KIRC : Kidney renal clear cell carcinoma
| Comparison | Statistical significance |
| Normal-vs-Primary | 7.878800E-01 |
|
KIRC : Kidney renal clear cell carcinoma Note
Cancer stage information is not available for 2 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
5.232000E-01 |
| Normal-vs-Stage2 |
4.725400E-01 |
| Normal-vs-Stage3 |
6.601400E-01 |
| Normal-vs-Stage4 |
9.002000E-01 |
| Stage1-vs-Stage2 |
3.097200E-01 |
| Stage1-vs-Stage3 |
9.853400E-01 |
| Stage1-vs-Stage4 |
4.918000E-01 |
| Stage2-vs-Stage3 |
3.538000E-01 |
| Stage2-vs-Stage4 |
5.232200E-01 |
| Stage3-vs-Stage4 |
6.026600E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma Note
Patient race information is not available for 7 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
9.421000E-01 |
| Normal-vs-AfricanAmerican |
1.332220E-01 |
| Normal-vs-Asian |
7.172200E-01 |
| Caucasian-vs-AfricanAmerican |
8.370200E-02 |
| Caucasian-vs-Asian |
6.611000E-01 |
| AfricanAmerican-vs-Asian |
7.054400E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
8.630400E-01 |
| Normal-vs-Female |
3.360600E-01 |
| Male-vs-Female |
1.995160E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
1.148230E-01 |
| Normal-vs-Age(41-60Yrs) |
7.718400E-01 |
| Normal-vs-Age(61-80Yrs) |
6.276400E-01 |
| Normal-vs-Age(81-100Yrs) |
5.617000E-01 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
7.246200E-02 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
1.912580E-01 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
4.323400E-01 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
4.155200E-01 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
4.329000E-01 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
7.813800E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma Note
Tumor grade information is not available for 3 samples and undetermined for 5 samples.
| Subtype descriptions |
| Grade 1 | Well differentiated (low grade) |
Grade 2 | Moderately differentiated (intermediate grade) |
| Grade 3 | Poorly differentiated (high grade) |
Grade 4 | Undifferentiated (high grade) |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Grade 1 |
6.098400E-01 |
| Normal-vs-Grade 2 |
4.151800E-01 |
| Normal-vs-Grade 3 |
1.196160E-01 |
| Normal-vs-Grade 4 |
2.385400E-01 |
| Grade 1-vs-Grade 2 |
9.710400E-01 |
| Grade 1-vs-Grade 3 |
1.554360E-01 |
| Grade 1-vs-Grade 4 |
1.217830E-01 |
| Grade 2-vs-Grade 3 |
2.654100E-02 |
| Grade 2-vs-Grade 4 |
6.826100E-02 |
| Grade 3-vs-Grade 4 |
8.545000E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma NOTE
Subtype information is not available for 153 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-ccA subtype |
6.713600E-01 |
| Normal-vs-ccB subtype |
7.572800E-01 |
| ccA subtype-vs-ccB subtype |
4.815000E-01 |
|
KIRC subtypes: Brooks SA et al, ClearCode34: A prognostic risk predictor for localized clear cell renal cell carcinoma. Eur Urol. 2014 Jul;66(1):77-84. doi: 10.1016/j.eururo.2014.02.035
|
KIRC : Kidney renal clear cell carcinoma Note
Cancer in nearby lymph nodes cannot be measured (NX) in 277 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
8.998000E-01 |
| Normal-vs-N1 |
1.268190E-01 |
| N0-vs-N1 |
3.244600E-01 |
|
|
